{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-004771","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2023-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.754528+00:00","generated_at":"2026-06-18T23:39:29.880368+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Genprex announces $4M registered direct offering of common stock and warrants","bullets":["Sold 3,809,524 shares and warrants to purchase same number at $1.05 combined price.","Gross proceeds ~$4M; net proceeds for working capital.","Warrants exercisable at $1.10, expire 5 years from issuance.","Closing expected March 1, 2023; A.G.P./Alliance Global Partners as placement agent.","Offering under effective shelf registration statement (S-3)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-004771","json":"https://secwatch.observer/filing/0001437749-23-004771.json","markdown":"https://secwatch.observer/filing/0001437749-23-004771.md","text":"https://secwatch.observer/filing/0001437749-23-004771.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923004771/0001437749-23-004771-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923004771/gnpx20230226_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T23:39:29.880368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58b3e5b7b33f0c7d9b6aa774086c0b6193c25229","claim":"Genprex, Inc. entered into Securities Purchase Agreement with accredited healthcare-focused institutional investor valued at aggregate gross proceeds approximately $4.0 million (effective 2023-02-26).","evidence_excerpt":"On February 26, 2023, Genprex, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an accredited healthcare-focused institutional investor (the “Purchaser”) pursuant to which the Company agreed to issue and sell to the Purchaser 3,809,524 shares (the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”) and common warrants to purchase an aggregate of 3,809,524 shares of Common Stock (the “Warrants”), in a registered direct offering (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774923004771/0001437749-23-004771-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"accredited healthcare-focused institutional investor"},{"label":"Value","value":"aggregate gross proceeds approximately $4.0 million"},{"label":"Effective","value":"2023-02-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}